6.3 IP3/DAG/Ca²⁺ Signaling and GPCR Diversity

Core Explanation

The Gαq–PLCβ axis: When a ligand (e.g., angiotensin II, acetylcholine at M1/M3 muscarinic receptors, α₁-adrenergic agonists, thrombin at PAR1) binds a Gαq-coupled GPCR, the activated receptor catalyzes GDP/GTP exchange on Gαq. Gαq-GTP binds and activates phospholipase C-β (PLCβ) , a cytosolic enzyme that cleaves the minor membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP₂) into two second messengers:

• Inositol 1,4,5-trisphosphate (IP₃): A small, water-soluble sugar-phosphate that diffuses through the cytosol and binds IP₃ receptors (IP₃Rs) on the endoplasmic reticulum membrane. IP₃Rs are ligand-gated Ca²⁺ channels; IP₃ binding opens the channel, releasing Ca²⁺ from the ER lumen ([Ca²⁺]ER ~ 100–800 µM) into the cytosol (resting [Ca²⁺]cyt ~ 100 nM), producing a rapid ~10–100-fold rise in cytosolic Ca²⁺.
• Diacylglycerol (DAG): A neutral lipid that remains embedded in the plasma membrane and recruits protein kinase C (PKC) from the cytosol. PKC requires both DAG (membrane tethering) and Ca²⁺ (conventional isoforms: PKCα, β, γ) or just DAG (novel isoforms: PKCδ, ε, η, θ) for activation. PKC phosphorylates serine/threonine residues on diverse targets regulating proliferation, differentiation, and cytoskeletal dynamics.

Ca²⁺ as a second messenger: Cytosolic free Ca²⁺ concentration is exquisitely regulated. The ~10,000-fold gradient across the plasma membrane (1–2 mM extracellular vs. ~100 nM cytosolic) and across the ER membrane provides enormous driving force for Ca²⁺ influx when channels open. Cells encode information in the amplitude, frequency, duration, and spatial localization of Ca²⁺ transients. For example, in hepatocytes, IP₃-dependent Ca²⁺ oscillations (frequency ~0.5–2 min⁻¹) encode agonist concentration — higher agonist → higher frequency → different transcriptional output.

Ca²⁺ effectors include:

• Calmodulin (CaM): A ubiquitous Ca²⁺-binding protein (4 EF-hand domains) that, in the Ca²⁺-bound state, activates numerous targets: CaM kinases (CaMKII, CaMKIV), calcineurin (a Ca²⁺/CaM-dependent phosphatase), myosin light-chain kinase (MLCK, regulating smooth muscle contraction and cell motility), and nitric oxide synthases.
• Troponin C: Skeletal and cardiac muscle Ca²⁺ sensor.
• Synaptotagmin: Ca²⁺ sensor for neurotransmitter vesicle fusion.
• Annexins: Ca²⁺-dependent membrane-binding proteins.

Ca²⁺ signal termination — restoration to resting levels:

• SERCA (Sarco/Endoplasmic Reticulum Ca²⁺-ATPase): Pumps Ca²⁺ back into the ER, consuming one ATP per two Ca²⁺ ions. This is the primary mechanism for refilling ER stores and restoring cytosolic [Ca²⁺].
• PMCA (Plasma Membrane Ca²⁺-ATPase): Expels Ca²⁺ across the plasma membrane. High affinity (Km ~0.1–1 µM), low capacity — fine-tunes basal levels.
• NCX (Na⁺/Ca²⁺ exchanger): Secondary active transporter using the Na⁺ electrochemical gradient (3 Na⁺ in, 1 Ca²⁺ out). Low affinity (Km ~1–5 µM), high capacity — dominates Ca²⁺ extrusion during large Ca²⁺ loads (e.g., in cardiac myocytes after each contraction).
• Mitochondrial Ca²⁺ uniporter (MCU): Uptakes Ca²⁺ into the mitochondrial matrix, buffering cytosolic Ca²⁺ and stimulating oxidative phosphorylation (Ca²⁺ activates pyruvate dehydrogenase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase).
• IP₃ degradation: IP₃ is sequentially dephosphorylated (IP₃ → IP₂ → IP₁ → inositol) or phosphorylated to IP₄. Li⁺ inhibits inositol monophosphatase, blocking PIP₂ resynthesis — the basis of lithium's therapeutic effect in bipolar disorder.

Molecular Components

Step-by-Step Mechanism: Angiotensin II → Vascular Smooth Muscle Contraction

1. Angiotensin II (AT1 receptor) binds its Gαq-coupled GPCR on vascular smooth muscle.
2. Gαq-GTP activates PLCβ.
3. PLCβ cleaves PIP₂ → IP₃ + DAG.
4. IP₃ diffuses to ER, opens IP₃Rs, releasing Ca²⁺ → [Ca²⁺]cyt rises from ~100 nM to ~500–1000 nM.
5. Ca²⁺ binds calmodulin; Ca²⁺/CaM activates myosin light-chain kinase (MLCK).
6. MLCK phosphorylates regulatory myosin light chains → myosin ATPase activated → actin-myosin cross-bridge cycling → contraction.
7. Concurrently, DAG activates PKC, which phosphorylates targets that sustain contraction and promote vascular remodeling (long-term).
8. Termination: IP₃ degraded; Ca²⁺ pumped back into ER by SERCA and extruded by NCX/PMCA; MLC phosphatase dephosphorylates myosin light chains → relaxation.

GPCR Diversity Beyond Gαs/Gαi/Gαq

All four major Gα families produce distinct downstream biochemistry:

• Gαs: AC ↑ → cAMP ↑ → PKA
• Gαi/o: AC ↓ → cAMP ↓; also Gβγ → GIRK channels (K⁺ efflux → hyperpolarization), inhibition of voltage-gated Ca²⁺ channels
• Gαq/11: PLCβ ↑ → IP₃/Ca²⁺ + DAG/PKC
• Gα12/13: RhoGEFs → RhoA activation → cytoskeletal reorganization (stress fiber formation, cell shape, migration). Important in embryonic development and cancer metastasis.

Many GPCRs couple to multiple G protein subtypes (pleiotropic coupling), and biased agonism (ligands that preferentially activate one G protein pathway over β-arrestin signaling) is an active frontier in drug development (e.g., biased μ-opioid agonists for analgesia with reduced respiratory depression).

Regulation

• IP₃R regulation: IP₃Rs exhibit biphasic Ca²⁺ regulation — moderate cytosolic Ca²⁺ enhances channel opening (positive feedback, generating Ca²⁺ puffs/sparks → waves), while high Ca²⁺ inhibits (negative feedback, preventing Ca²⁺ overload). IP₃R phosphorylation by PKA, PKC, and CaMKII modulates sensitivity.
• PKC regulation: Conventional PKC is autoinhibited by a pseudosubstrate domain; DAG binding to the C1 domain and Ca²⁺ binding to the C2 domain release autoinhibition. Phorbol esters (e.g., PMA) are potent DAG mimetics and tumor promoters, chronically activating PKC.
• PIP₂ resynthesis: Rapidly replenished by sequential phosphorylation: phosphatidylinositol → PI(4)P → PI(4,5)P₂ by PI 4-kinase and PI(4)P 5-kinase. This cycle is crucial — sustained signaling requires continuous PIP₂ supply.
• STIM-Orai store-operated Ca²⁺ entry: When ER Ca²⁺ stores are depleted, the ER Ca²⁺ sensor STIM1 oligomerizes and translocates to ER–plasma membrane junctions, where it gates Orai channels, allowing sustained Ca²⁺ influx from the extracellular space to refill ER stores. This couples IP₃-mediated store depletion to sustained Ca²⁺ signaling.

Energy

• PIP₂ resynthesis: Each round of phosphorylation costs ATP.
• Ca²⁺ pumping: SERCA consumes 1 ATP per 2 Ca²⁺; PMCA consumes 1 ATP per 1 Ca²⁺. Restoration of resting Ca²⁺ levels after a large transient is energetically expensive — in cardiac muscle, SERCA accounts for ~15–20% of total ATP consumption.
• NCX: Uses the Na⁺ gradient (established by Na⁺/K⁺-ATPase) — indirectly fueled by ATP.

Experimental Evidence

• Berridge & Irvine (1984): Demonstrated that IP₃ mobilizes Ca²⁺ from permeabilized pancreatic acinar cells, establishing IP₃ as the Ca²⁺-mobilizing second messenger. This resolved the long-standing puzzle of how extracellular signals release intracellular Ca²⁺.
• Nishizuka (1980s): Discovered and characterized PKC, demonstrating its activation by DAG and Ca²⁺, and its role as the receptor for tumor-promoting phorbol esters.
• Tsien & colleagues: Developed fluorescent Ca²⁺ indicators (Fura-2, Fluo-4, genetically encoded GCaMPs) enabling real-time visualization of Ca²⁺ dynamics in single living cells, revealing oscillations, waves, and sparks.
• STIM/Orai discovery (2005–2006): RNAi screens identified STIM1 as the ER Ca²⁺ sensor and Orai1 as the CRAC (Ca²⁺ release-activated Ca²⁺) channel, resolving the mechanism of store-operated Ca²⁺ entry — crucial for immune cell function (mutations cause severe combined immunodeficiency).

Disease / Clinical Relevance

• Malignant hyperthermia: Mutations in the ryanodine receptor (RyR1, another ER Ca²⁺ release channel in skeletal muscle) cause uncontrolled Ca²⁺ release upon exposure to halogenated anesthetics, leading to sustained muscle contraction, hyperthermia, and metabolic crisis.
• Cardiac hypertrophy and failure: Chronic Gαq signaling (e.g., from angiotensin II, endothelin-1) drives pathological cardiac remodeling via calcineurin-NFAT and CaMKII-HDAC pathways.
• Lithium therapy: Li⁺ inhibits inositol monophosphatase, depleting free inositol and dampening PIP₂ resynthesis. In neurons, this attenuates hyperactive IP₃/DAG signaling, contributing to mood stabilization in bipolar disorder.
• PKC in cancer: Phorbol esters are tumor promoters because chronic PKC activation drives proliferation. Conversely, some PKC isozymes act as tumor suppressors — context-dependent roles complicate PKC-targeted therapy.

High-Yield Summary

• Gαq → PLCβ → PIP₂ cleavage → IP₃ (soluble, releases ER Ca²⁺ via IP₃R) + DAG (membrane-bound, activates PKC).
• Ca²⁺ encodes information in amplitude, frequency, duration, and subcellular localization. Key effectors: calmodulin, troponin C, synaptotagmin.
• Ca²⁺ restoration: SERCA (ER reuptake), PMCA (PM efflux), NCX (Na⁺ gradient-driven), mitochondrial MCU.
• GPCR diversity: Gαs (cAMP ↑), Gαi (cAMP ↓), Gαq (IP₃/Ca²⁺ + DAG/PKC), Gα12/13 (RhoA → cytoskeleton).
• Store-operated Ca²⁺ entry (STIM-Orai) links ER depletion to sustained Ca²⁺ influx.

Practice Questions

Q1: Explain why Li⁺ treatment dampens IP₃/DAG signaling and how this relates to its therapeutic use in bipolar disorder.

A1: Li⁺ is an uncompetitive inhibitor of inositol monophosphatase (IMPase), the enzyme that converts inositol monophosphate to free inositol, the precursor for PIP₂ resynthesis. By blocking inositol recycling, Li⁺ depletes cellular inositol pools, reducing PIP₂ levels. With less PIP₂ available as substrate, PLCβ produces less IP₃ and DAG upon receptor activation, attenuating the entire IP₃/Ca²⁺ and DAG/PKC signaling axis. In bipolar disorder, hyperactivity of this pathway in certain neuronal populations may contribute to manic episodes; Li⁺ dampens this overactive signaling, providing mood stabilization. This is the "inositol depletion hypothesis" of lithium action.

Q2: A cell is stimulated with a Gαq-coupled agonist in Ca²⁺-free extracellular medium. What Ca²⁺ response would you observe, and what would happen upon repeated stimulation without allowing recovery time?

A2: The first stimulation would produce a normal Ca²⁺ transient — IP₃-mediated ER Ca²⁺ release does not require extracellular Ca²⁺. However, without extracellular Ca²⁺, store-operated Ca²⁺ entry (STIM-Orai) cannot replenish ER stores, and PMCA/NCX continue to extrude Ca²⁺ from the cell. Repeated stimulation would yield progressively smaller Ca²⁺ transients as ER stores become depleted, eventually producing no response. This demonstrates that sustained signaling requires store-operated Ca²⁺ entry to maintain ER Ca²⁺ stores.

Q3: Predict the effect of a mutation that renders the IP₃ receptor insensitive to IP₃ but preserves its Ca²⁺ sensitivity. How would this affect Ca²⁺ signaling?

A3: The IP₃ receptor could not be gated by agonist stimulation (no IP₃ → no channel opening → no Ca²⁺ release from ER). The cell would be unresponsive to all Gαq-coupled and RTK-coupled stimuli (which generate IP₃ via PLCβ or PLCγ). The residual Ca²⁺ sensitivity could allow Ca²⁺-induced Ca²⁺ release (CICR) if another mechanism (e.g., voltage-gated Ca²⁺ channels) provided an initial Ca²⁺ trigger, but the primary agonist-evoked Ca²⁺ mobilization would be abolished. This would impair all IP₃-dependent processes: secretion, contraction, gene expression, and metabolism in affected cells.

Common Misconceptions

• ❌ "IP₃ and DAG both diffuse into the cytoplasm." → IP₃ is water-soluble and freely diffusible; DAG is a neutral lipid and remains embedded in the plasma membrane, acting as a local membrane-bound activator.
• ❌ "Ca²⁺ is simply an on-off switch." → Ca²⁺ signals are highly complex — cells decode frequency-modulated Ca²⁺ oscillations to drive distinct transcriptional programs. Amplitude, spatial localization (microdomains near channels vs. global), and duration all carry information.
• ❌ "All GPCRs signal through cAMP." → Different Gα families drive distinct effectors. Gαs → cAMP, Gαi → ↓cAMP, Gαq → IP₃/DAG, Gα12/13 → RhoA. Many receptors couple to multiple G proteins.
• ❌ "PLC only generates second messengers at the plasma membrane." → While plasma membrane PIP₂ is the canonical substrate, PLC isoforms can also act at the Golgi (PLCγ, PLCε) and nuclear PIP₂ pools exist, contributing to localized signaling.